HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.

Abstract
Peroxisome proliferator-activated receptor (PPAR)-γ is a ligand-activated transcription factor and regulates inflammation. Posttranslational modifications regulate the function of PPARγ, potentially affecting inflammation. PPARγ contains a mitogen-activated protein kinase (MAPK) site, and phosphorylation by extracellular signal-regulated kinase (ERK)-1/2 leads to inhibition of PPARγ. This study investigated the kinetics of PPARγ expression and activation in parenchymal and immune cells in sepsis using the MAPK/ERK kinase (MEK)-1 inhibitor, an upstream kinase of ERK1/2. Adult male Sprague Dawley rats were subjected to polymicrobial sepsis by cecal ligation and puncture. Rats received intraperitoneal injection of vehicle or the MEK1 inhibitor PD98059 (5 mg/kg) 30 min before cecal ligation and puncture. Rats were euthanized at 0, 1, 3, 6 and 18 h after cecal ligation and puncture. Control animals used were animals at time 0 h. Lung, plasma and peripheral blood mononuclear cells (PBMCs) were collected for biochemical assays. In vehicle-treated rats, polymicrobial sepsis resulted in significant lung injury. In the lung and PBMCs, nuclear levels of PPARγ were decreased and associated with an increase in phosphorylated PPARγ and phosphorylated ERK1/2 levels. Treatment with the MEK1 inhibitor increased the antiinflammatory plasma adipokine adiponectin, restored PPARγ expression in PBMCs and lung, and decreased lung injury. The inflammatory effects of sepsis cause changes in PPARγ expression and activation, in part, because of phosphorylation of PPARγ by ERK1/2. This phosphorylation can be reversed by ERK1/2 inhibition, thereby improving lung injury.
AuthorsJennifer M Kaplan, Paul W Hake, Alvin Denenberg, Marchele Nowell, Giovanna Piraino, Basilia Zingarelli
JournalMolecular medicine (Cambridge, Mass.) (Mol Med) 2010 Nov-Dec Vol. 16 Issue 11-12 Pg. 491-7 ISSN: 1528-3658 [Electronic] England
PMID20809049 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adiponectin
  • Anti-Inflammatory Agents
  • Ligands
  • PPAR gamma
  • Transcription Factors
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
Topics
  • Adiponectin (blood)
  • Animals
  • Anti-Inflammatory Agents (pharmacokinetics)
  • Down-Regulation
  • Ligands
  • Lung (physiopathology)
  • Male
  • Mitogen-Activated Protein Kinase 3 (antagonists & inhibitors, metabolism)
  • Mitogen-Activated Protein Kinases (metabolism)
  • PPAR gamma (metabolism)
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis (metabolism, microbiology)
  • Transcription Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: